GA
ELGX

Geneva Advisors’s Endologix Inc ELGX Stock Holding History

Geneva Advisors’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,786
Closed -$312K – 711
2013
Q4 		$312K Buy
1,786
+30
+2% +$5.16K 0.01% 396
2013
Q3 		$283K Buy
1,756
+172
+11% +$27.1K 0.01% 405
2013
Q2 		$210K Buy
+1,584
New +$224K ﹤0.01% 385

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Geneva Advisors's ELGX Position: Q1 2014 in Review

Geneva Advisors sold out of Endologix Inc (ELGX) in Q1 2014, closing a stake of 1,786 shares — an estimated $312K sold.

Geneva Advisors first reported a position in ELGX in Q2 2013 and held it in 3 quarters. The position peaked at $312K in Q4 2013. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2014.

  • Geneva Advisors reported no remaining Endologix Inc position as of Q1 2014 after selling out during the quarter.
  • Geneva Advisors sold 1,786 Endologix Inc shares in Q1 2014, an estimated $312K.
  • Geneva Advisors first reported a position in Endologix Inc in Q2 2013 and held it in 3 quarters.
  • Geneva Advisors's Endologix Inc position peaked at $312K in Q4 2013.
  • 129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2014.

Based on Geneva Advisors's 13F filing for Q1 2014, filed 5 May 2014.